Growth Differentiation Factor 2
"Growth Differentiation Factor 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A growth differentiation factor that plays a regulatory role as a paracrine factor for a diverse array of cell types during EMBRYONIC DEVELOPMENT and in the adult tissues. Growth differentiation factor 2 is also a potent regulator of CHONDROGENESIS and was previously referred to as bone morphogenetic protein 9.
Descriptor ID |
D055427
|
MeSH Number(s) |
D12.644.276.954.200.910 D12.644.276.954.300.200 D12.776.467.942.200.910 D12.776.467.942.300.200 D23.529.942.200.910 D23.529.942.300.200
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Growth Differentiation Factor 2".
Below are MeSH descriptors whose meaning is more specific than "Growth Differentiation Factor 2".
This graph shows the total number of publications written about "Growth Differentiation Factor 2" by people in this website by year, and whether "Growth Differentiation Factor 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Growth Differentiation Factor 2" by people in Profiles.
-
Wang W, Chun H, Baek J, Sadik JE, Shirazyan A, Razavi P, Lopez N, Lyons KM. The TGF? type I receptor TGF?RI functions as an inhibitor of BMP signaling in cartilage. Proc Natl Acad Sci U S A. 2019 07 30; 116(31):15570-15579.
-
Dayoub H, Dumont RJ, Li JZ, Dumont AS, Hankins GR, Kallmes DF, Helm GA. Human mesenchymal stem cells transduced with recombinant bone morphogenetic protein-9 adenovirus promote osteogenesis in rodents. Tissue Eng. 2003 Apr; 9(2):347-56.
-
Dumont RJ, Dayoub H, Li JZ, Dumont AS, Kallmes DF, Hankins GR, Helm GA. Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery. 2002 Nov; 51(5):1239-44; discussion 1244-5.